Literature DB >> 22815137

Sorafenib combined with locoregional therapy prior to liver transplantation for hepatocellular carcinoma: an update on a previous case report.

Parsia A Vagefi, Ryutaro Hirose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22815137     DOI： 10.1007/s12029-012-9417-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  5 in total

1.  Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system.

Authors:  K Washburn; E Edwards; A Harper; R Freeman
Journal:  Am J Transplant       Date:  2010-05-10       Impact factor: 8.086

2.  A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Authors:  Francis Y Yao; Ryutaro Hirose; Jeanne M LaBerge; Timothy J Davern; Nathan M Bass; Robert K Kerlan; Raphael Merriman; Sandy Feng; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2005-12       Impact factor: 5.799

Review 3.  Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?

Authors:  Parsia A Vagefi; Ryutaro Hirose
Journal:  J Gastrointest Cancer       Date:  2010-12

4.  Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].

Authors:  K Hoffmann; H Glimm; B Radeleff; G Richter; C Heining; I Schenkel; A Zahlten-Hinguranage; P Schirrmacher; J Schmidt; M W Büchler; D Jaeger; C von Kalle; P Schemmer
Journal:  BMC Cancer       Date:  2008-11-26       Impact factor: 4.430

5.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079
  5 in total
  1 in total

1.  Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma.

Authors:  Eun Jin Yoo; Hye Sun Shin; Seung Up Kim; Dong Jin Joo; Jun Yong Park; Gi Hong Choi; Do Young Kim; Sang Hoon Ahn; Jinsil Seong; Myung Joo Koh; Kwang-Hyub Han; Chae Yoon Chon
Journal:  Onco Targets Ther       Date:  2013-06-21       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.